These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 5887150
1. [Secondary hyperaldosteronism as a secondary disease in intractable cardiac decompensation]. Antalóczy Z, Ludvigh G. Z Arztl Fortbild (Jena); 1965 Jul 15; 59(14):757-61. PubMed ID: 5887150 [No Abstract] [Full Text] [Related]
2. [Electrocardiographic observations in secondary aldosteronism]. Hilmer W. Med Klin; 1972 Jan 28; 67(4):128-33. PubMed ID: 5060139 [No Abstract] [Full Text] [Related]
3. [Aldosterone and aldosterone antagonists in surgery]. Oelert H. Anaesthesist; 1971 Jun 28; 20(6):205-11. PubMed ID: 4943021 [No Abstract] [Full Text] [Related]
4. [Secondary aldosteronism following surgery using the heart-lung machine and its regulation with Aldactone]. Gleichmann U, Bostroem B, Kreuzer H, Löhr B. Anaesthesist; 1965 Dec 28; 14(12):355-9. PubMed ID: 5870012 [No Abstract] [Full Text] [Related]
5. Pseudo-intractable heart failure with edema: some of the mechanisms and means for restoring response to treatment. Gold H, Kwit NT, Golfinos AJ, Messeloff CR, Zahm W, Goessel E. J Clin Pharmacol J New Drugs; 1969 Dec 28; 9(2):104-17. PubMed ID: 5253269 [No Abstract] [Full Text] [Related]
6. The treatment of heart failure in the "intractable" (refractory) phase. Lasser RP. Adv Cardiopulm Dis; 1966 Dec 28; 3():296-304. PubMed ID: 6005642 [No Abstract] [Full Text] [Related]
7. [Myocardial hyperexcitability in decompensated cardiopathies. Effect of spironolactone]. Tourniaire A, Blum J, Guyot R, Madignier M. Sem Hop; 1969 Apr 26; 45(20):1388-92. PubMed ID: 4182541 [No Abstract] [Full Text] [Related]
9. [Heart failure therapy with digitalis and spironolactone--studies within the scope of preoperative treatment before lung resection]. Daum S, Goerg R, Mack D, Wang D. Prax Klin Pneumol; 1984 Sep 26; 38(9):406-11. PubMed ID: 6504840 [No Abstract] [Full Text] [Related]
12. [Intolerance to spironolactone in refractory cardiac insufficiency. Probable changes in the aldosterone receptors. Study of 11 cases]. Sänchez Torres G, Posadas C, Boyer JL, Guzmán Lara J, Serrano P. Arch Inst Cardiol Mex; 1981 Sep 26; 51(3):233-40. PubMed ID: 6456707 [No Abstract] [Full Text] [Related]
13. [Hyperaldosteronism and the use of aldactone in cardiac insufficiency]. Korochkin IM, Matveeva IV, Sidorenko BA, Arshakuni RO. Kardiologiia; 1968 Dec 26; 8(12):74-81. PubMed ID: 5736746 [No Abstract] [Full Text] [Related]
14. [Diuresis therapy in hyperaldosteronism]. Wallnöfer H, Hanusch M. Wien Med Wochenschr; 1966 Dec 24; 116(52):1159-64. PubMed ID: 5996768 [No Abstract] [Full Text] [Related]
15. [Recent advances in the physiopathology and therapy of edematogenic states]. Pupita F, Bartoli E, Molaschi M. Clin Ter; 1966 Nov 30; 39(4):347-72. PubMed ID: 6011954 [No Abstract] [Full Text] [Related]
16. [The cardiologist faced with electrolyte disorders]. Jouve A. Acta Cardiol; 1973 Nov 30; ():Suppl 17:2-14. PubMed ID: 4271960 [No Abstract] [Full Text] [Related]